Abbott Inaugurates New Global Manufacturing Facility in Ireland
The Kilkenny facility is part of a EUR 440 million investment in Ireland, which includes a significant expansion of the company’s Donegal site, where a further 200 jobs are being created.
Abbott | 19/11/2024 | By Aishwarya
Abbott Launches New Technology to Support Advanced Cardiac Mapping
Abbott's investigational Volt PFA System was designed to overcome prior limitations in PFA systems by pairing a balloon-in-basket catheter with Abbott's EnSits X EP System, an heart mapping solution.
Abbott | 11/10/2024 | By Aishwarya
Abbott Announces Availability of Lingo Continuous Glucose Monitor in US
Lingo is based on Abbott's world-leading FreeStyle Libre continuous glucose monitoring technology, now used by more than 6 million people with diabetes globally.
Abbott | 06/09/2024 | By Aishwarya | 208
Abbott Signs Global Partnership with Medtronic for Insulin Delivery Devices
Abbott has inked a global partnership with Medtronic to collaborate on an integrated continuous glucose monitoring (CGM) system based on Abbott's most advanced, FreeStyle Libre technology that will connect with Medtronic's automated insulin delivery (AID) and smart insulin pen systems.
Abbott | 08/08/2024 | By Aishwarya | 148
Powder formulas, Similac, Alimentum & EleCare manufactured at Michigan plant are recalled by Abbott
Abbott is voluntarily recalling these products after four consumer complaints related to Cronobacter sakazakii or Salmonella Newport in infants who had consumed powder infant formula manufactured in this facility
Abbott | 20/02/2022 | By Darshana | 305
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy